Skip to Main Content

Author Details

Olga Bogatyrova
German Cancer Research Center
2010
16
11
PMIDPaper TitleJournal TitlePublished Year
37940144Novel Methionine Aminopeptidase 2 Inhibitor M8891 Synergizes with VEGF Receptor Inhibitors to Inhibit Tumor Growth of Renal Cell Carcinoma Models.Mol Cancer Ther2024
34942492Brain penetration and efficacy of tepotinib in orthotopic patient-derived xenograft models of MET-driven non-small cell lung cancer brain metastases.Lung Cancer2022
36142605Identification of <i>NHLRC1</i> as a Novel AKT Activator from a Lung Cancer Epigenome-Wide Association Study (EWAS).Int J Mol Sci2022
33595421Differentially methylated regions within lung cancer risk loci are enriched in deregulated enhancers.Epigenetics2022
33984662FGFR1 overexpression in non-small cell lung cancer is mediated by genetic and epigenetic mechanisms and is a determinant of FGFR1 inhibitor response.Eur J Cancer2021
31053176DNA methylation at an enhancer of the three prime repair exonuclease 2 gene (TREX2) is linked to gene expression and survival in laryngeal cancer.Clin Epigenetics2019
30537516Molecular Evolution of Early-Onset Prostate Cancer Identifies Molecular Risk Markers and Clinical Trajectories.Cancer Cell2018
26780610DNA methylation dynamics during B cell maturation underlie a continuum of disease phenotypes in chronic lymphocytic leukemia.Nat Genet2016
24002901Global alterations of DNA methylation in cholangiocarcinoma target the Wnt signaling pathway.Hepatology2014
25066126Intratumor DNA methylation heterogeneity reflects clonal evolution in aggressive prostate cancer.Cell Rep2014
24356097Evolution of DNA methylation is linked to genetic aberrations in chronic lymphocytic leukemia.Cancer Discov2014
23410972Integrative genomic analyses reveal an androgen-driven somatic alteration landscape in early-onset prostate cancer.Cancer Cell2013
24105274Mutations in regulators of the epigenome and their connections to global chromatin patterns in cancer.Nat Rev Genet2013
23635773HPV-related methylation signature predicts survival in oropharyngeal squamous cell carcinomas.J Clin Invest2013
21423093A novel MECA3 region in human 3p21.3 harboring putative tumor suppressor genes and oncogenes.Exp Oncol2011
20693965Genetic and epigenetic changes of NKIRAS1 gene in human renal cell carcinomas.Exp Oncol2010
  • 1 - 16 of 16

Recommended Authors

Reanne Bowlby
Career Start Year 2015
Number of shared co-authors 1
Harshad S Mahadeshwar
The University of MD Anderson Cancer Center
Career Start Year 2014
Number of shared co-authors 0
Hui Shen
Van Andel Institute
Career Start Year 2010
Number of shared co-authors 1
Larissa A Pikor
Ottawa Hospital Research Institute
Career Start Year 2010
Number of shared co-authors 2
Hyunchul Jung
Wellcome Sanger Institute
Career Start Year 2009
Number of shared co-authors 0
Oscar Krijgsman
The Netherlands Cancer Institute
Career Start Year 2008
Number of shared co-authors 3
Salvatore Piscuoglio
University of Basel
Career Start Year 2008
Number of shared co-authors 1
Wei Zhang
Montefiore Medical Center
Career Start Year 2008
Number of shared co-authors 0
Siyuan Zheng
Greehey Children's Cancer Research Institute
Career Start Year 2007
Number of shared co-authors 2
Ritu Roy
University of California San Francisco.
Career Start Year 2007
Number of shared co-authors 0
Barry S Taylor
Memorial Sloan Kettering Cancer Center
Career Start Year 2006
Number of shared co-authors 5
Anderly C Chueh
Biomedicine Discovery Institute, Monash University
Career Start Year 2005
Number of shared co-authors 1
Nikolaus Schultz
Memorial Sloan Kettering Cancer Center
Career Start Year 2003
Number of shared co-authors 2
Lixia Diao
The University of Texas MD Anderson Cancer Center
Career Start Year 2003
Number of shared co-authors 0
Leslie Cope
Johns Hopkins University School of Medicine
Career Start Year 2003
Number of shared co-authors 0
Jianhua Zhang
University of Texas MD Anderson Cancer Center
Career Start Year 2003
Number of shared co-authors 0
Luciano G Martelotto
Monash University
Career Start Year 2000
Number of shared co-authors 1
Jonathan K Killian
From Foundation Medicine
Career Start Year 1999
Number of shared co-authors 0
Michal R Schweiger
Institute for Translational Epigenetics, University of Cologne
Career Start Year 1999
Number of shared co-authors 11
Barbara A Weir
Janssen Research and Development LLC
Career Start Year 1997
Number of shared co-authors 0
Anthony J Iafrate
Massachusetts General Hospital
Career Start Year 1997
Number of shared co-authors 4
Li Ding
McDonnell Genome Institute, Washington University School of Medicine
Career Start Year 1997
Number of shared co-authors 5
Manon van Engeland
Maastricht University Medical Center
Career Start Year 1996
Number of shared co-authors 1
Peter S Hammerman
Novartis Institutes for BioMedical Research
Career Start Year 1996
Number of shared co-authors 1
Timothy A Chan
Cleveland Clinic.
Career Start Year 1994
Number of shared co-authors 6
Tatsuhiro Shibata
Kurume University School of Medicine
Career Start Year 1993
Number of shared co-authors 1
Phillip A Futreal
The University of Texas MD Anderson Cancer Center
Career Start Year 1991
Number of shared co-authors 3
Joseph F Costello
University of California san francisco
Career Start Year 1991
Number of shared co-authors 5
Wan L Lam
British Columbia Cancer Research Institute
Career Start Year 1987
Number of shared co-authors 2
Matthew Meyerson
Broad Institute
Career Start Year 1983
Number of shared co-authors 23

Collaborators

Christoph Plass
German Cancer Research Center
Co-authored papers 11
Yassen Assenov
German Cancer Research Center (DKFZ)
Co-authored papers 6
Dieter Weichenhan
German Cancer Research Center (DKFZ)
Co-authored papers 5
Benedikt Brors
German Cancer Research Center (DKFZ)
Co-authored papers 4
Lars Feuerbach
German Cancer Research Center (DKFZ)
Co-authored papers 3
Thorsten Schlomm
Charite - University Hospital Berlin
Co-authored papers 3
Roland Eils
Berlin Institute of Health (BIH) and Charite
Co-authored papers 3
Peter Lichter
German Cancer Research Center (DKFZ)
Co-authored papers 3
Jan O Korbel
European Bioinformatics Institute (EMBL-EBI)
Co-authored papers 3
Clarissa Gerh??user
German Cancer Research Center (DKFZ)
Co-authored papers 3
Ronald Simon
Institute of Pathology, University Medical Center Hamburg-Eppendorf
Co-authored papers 3
Guido Sauter
Institute of Pathology, University Medical Center Hamburg-Eppendorf
Co-authored papers 3
Joachim Weischenfeldt
University of Copenhagen
Co-authored papers 3
Thomas J Kipps
University of California San Diego
Co-authored papers 2
Benjamin Raeder
Co-authored papers 2
Angela Risch
Allergy-Cancer-BioNano Research Centre, University of Salzburg
Co-authored papers 2
Christof von Kalle
Berlin Institute of Health at Charite-Universitatsmedizin Berlin
Co-authored papers 2
Adrian M St??tz
St. Anna Children's Cancer Research Institute (CCRI)
Co-authored papers 2
Martina Kluth
Institute of Pathology, University Medical Center Hamburg-Eppendorf
Co-authored papers 2
Holger S??ltmann
German Cancer Research Center (DKFZ)
Co-authored papers 2
Markus Graefen
University Hospital Frankfurt, Goethe University Frankfurt am Main
Co-authored papers 2
Christina M??ller-Koop
Institute of Pathology, University Medical Center Hamburg-Eppendorf
Co-authored papers 2
Laura Z Rassenti
University of California San Diego
Co-authored papers 2
Hans-J??rg Warnatz
Max Planck Institute for Molecular Genetics
Co-authored papers 2
Eugene R Zabarovsky
Co-authored papers 2
Hartwig Huland
Martini-Klinik Prostate Cancer Center, University Hospital-Hamburg-Eppendorf
Co-authored papers 2
Marie-Laure Yaspo
Max Planck Institute for Molecular Genetics
Co-authored papers 2
Vyacheslav Amstislavskiy
Max-Planck-Institute for Molecular Genetics
Co-authored papers 2
Matthias Schlesner
University of Augsburg
Co-authored papers 2
Chris Lawerenz
German Cancer Research Center (DKFZ)
Co-authored papers 2
Release 1.2